Wells Fargo在Masimo的超重评分上保持超重, Wells Fargo maintains overweight rating on Masimo, citing strong execution and growth in healthcare tech.

Wells Fargo在公司投资日之后对Masimo(MASI)保持超重评级, Wells Fargo keeps an overweight rating on Masimo (MASI) after the company’s investor day, citing management’s confidence in hitting long-term revenue goals. 该公司强调马西莫目前在脉搏食氧测量和远程病人监测方面进行的创新,同时医院和家庭护理的使用量也在增加。 The firm highlights Masimo’s ongoing innovation in pulse oximetry and remote patient monitoring, along with growing use in hospitals and home care. 尽管没有新的财政预测,但Wells Fargo赞扬该公司的执行和在扩大的保健技术部门中的强势地位,维持其价格目标并表示继续乐观。 Despite no new financial projections, Wells Fargo praises the company’s execution and strong position in the expanding healthcare tech sector, maintaining its price target and expressing continued optimism.